Author Archives: Jawad Kamal

4 Step Action Plan for Digital Transformation in Mid-Sized Pharma

digital transformation action plan

Digital Transformation is a very broad concept, but at its core it means leveraging computers and other digital technologies to fundamentally change the way a business operates. A simple example…Uber transformed the taxi industry by combining a mobile application for users, a digital dispatching system and a digital payments model.  For Pharma companies, digital transformation

5 Essential Features in a Regulatory Management System

RMS Life Sciences

If you are in the process of researching and selecting a regulatory management system RMS), it’s essential to understand what the key capabilities are (you can read about these here). But equally important is identifying if the RMS you are looking at includes five essential features. What are those features? Let’s take a look.   1.

What is a Regulatory Management System?

What is a regulatory management system

Regulatory compliance is complex and time-consuming for life sciences organizations. But there are ways to make it easier with the assistance of technology. In a recent webinar, MarieLouise Abi Hanna, RMS Product Lead, provided insights and guidance on regulatory management systems (RMS) and how they help pharmaceutical, medical device, and biotech companies build and maintain

Meet My New Superhero: The Quality Manager

Quality Manager - Super Hero

I recently met with a Scigeniq customer – I will call her Tara – and she made a profound impression on me. She personified everything I find so amazing about the people who manage quality in pharma companies. Tara is the quality manager for a pharma company. So, of course, she is responsible for designing,

A Transformative Opportunity Awaits the MENA Pharma Industry: Are You Ready?

MENA Pharma

Last week a very impressive group of Pharma industry leaders gathered in Jordan to talk about “Digital Transformation” and the state of manufacturing and quality systems. At this remarkable event, sponsored by Scigeniq, a very clear thesis emerged.  In essence, the shared belief among the speakers and participants is that Pharma companies in the Middle